Merck seeks authorization for what would be first pill to treat COVID-19, and AstraZeneca reports positive results for antibody treatment
October 11, 2021 at 10:43 AM EDT
The global tally of confirmed cases of the coronavirus-borne illness COVID-19 edged closer to 238 million on Monday, as Merck submitted an application to the Food and Drug Administration for emergency authorization of what would be the first pill-based treatment for the deadly illness.
